JKN-23051
N/A
Report date: 2024/09/10 20:00:04
Base Information
Drug NameJKN-23051
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLangyu Pharmaceutical Technology (Hangzhou) Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesLangyu Pharmaceutical Technology (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A